BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29895486)

  • 1. Left Ventricular Assist Devices in Pulmonary Hypertension Group 2 With Significantly Elevated Pulmonary Vascular Resistance: A Bridge to Cure.
    Selim AM; Wadhwani L; Burdorf A; Raichlin E; Lowes B; Zolty R
    Heart Lung Circ; 2019 Jun; 28(6):946-952. PubMed ID: 29895486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
    Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation.
    Uriel N; Imamura T; Sayer G; Agarwal R; Sims DB; Takayama H; John R; Pagani FD; Naka Y; Sundareswaran KS; Farrar DJ; Jorde UP;
    J Card Fail; 2019 Oct; 25(10):777-784. PubMed ID: 30904557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
    J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates.
    Salzberg SP; Lachat ML; von Harbou K; Zünd G; Turina MI
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):222-5. PubMed ID: 15691674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.
    Tedford RJ; Hemnes AR; Russell SD; Wittstein IS; Mahmud M; Zaiman AL; Mathai SC; Thiemann DR; Hassoun PM; Girgis RE; Orens JB; Shah AS; Yuh D; Conte JV; Champion HC
    Circ Heart Fail; 2008 Nov; 1(4):213-9. PubMed ID: 19808294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.
    Kutty RS; Parameshwar J; Lewis C; Catarino PA; Sudarshan CD; Jenkins DP; Dunning JJ; Tsui SS
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1237-42. PubMed ID: 23345184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion.
    Sharma S; Ruiz J; Paghdar S; Desai S; Goswami R
    Transplant Proc; 2023 Dec; 55(10):2462-2469. PubMed ID: 37980253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study.
    Martin J; Siegenthaler MP; Friesewinkel O; Fader T; van de Loo A; Trummer G; Berchtold-Herz M; Beyersdorf F
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):971-7. PubMed ID: 15144997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.
    Gulati G; Ruthazer R; Denofrio D; Vest AR; Kent D; Kiernan MS
    J Card Fail; 2021 May; 27(5):552-559. PubMed ID: 33450411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices.
    John R; Liao K; Kamdar F; Eckman P; Boyle A; Colvin-Adams M
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):447-52. PubMed ID: 20435321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Zimpfer D; Zrunek P; Sandner S; Schima H; Grimm M; Zuckermann A; Wolner E; Wieselthaler G
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute response test to adaptive servo-ventilation, a possible modality to assessing the reversibility of pulmonary vascular resistance.
    Hieda M; Seguchi O; Mutara Y; Sunami H; Sato T; Yanase M; Hiroki H; Fujita T; Nakatani T
    J Artif Organs; 2015 Sep; 18(3):280-3. PubMed ID: 25809453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical circulatory support restores eligibility for heart transplant in patients with significant pulmonary hypertension.
    Biełka A; Kalinowski M; Hawranek M; Małyszek-Tumidajewicz J; Pacholewicz J; Kowalczuk-Wieteska A; Ratman K; Kubiak G; Król B; Przybyłowski P; Zembala M; Zembala MO
    Kardiol Pol; 2020 Oct; 78(10):1008-1014. PubMed ID: 32692025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Hypertension After Heart Transplantation in Patients Bridged with the Total Artificial Heart.
    Shah R; Patel DB; Mankad AK; Rennyson SL; Tang DG; Quader MA; Smallfield MC; Kasirajan V; Shah KB
    ASAIO J; 2016; 62(1):69-73. PubMed ID: 26479463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.
    Kumarasinghe G; Jain P; Jabbour A; Lai J; Keogh AM; Kotlyar E; Jansz P; Macdonald PS; Hayward CS
    ESC Heart Fail; 2018 Aug; 5(4):695-702. PubMed ID: 29573567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.